on NANOBIOTIX (EPA:NANO)
NANOBIOTIX to Participate in Investor Conferences in November
NANOBIOTIX, a biotechnology company focused on nanoparticle-based cancer therapies, announced its participation in multiple investor conferences this November. The company aims to discuss its innovative approaches and engage with investors through these platforms.
The conferences include Guggenheim’s Inaugural Healthcare Innovation Conference in Boston from November 11-13, Stifel Healthcare Conference in New York from November 18-19, and Jefferies London Healthcare Conference from November 19-21. Key figures such as Laurent Levy, CEO, and Bart van Rhijn, CFO, will be presenting at these events.
These presentations will also be webcast live and will be available for replay on the NANOBIOTIX website, providing broader access to stakeholders unable to attend in person.
R. P.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all NANOBIOTIX news